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Mycoplasma gallisepticum (MG), one of the most pathogenic Mycoplasmas, can
cause chronic respiratory disease (CRD) in chickens. It has been suggested that
micro-ribonucleic acids (miRNAs) are involved in microbial pathogenesis. However, little
is known about the roles of miRNAs in MG infection. Previously, we found by deep
sequencing that gga-miR-19a was significantly up-regulated in the lungs of MG-infected
chicken embryos. In this work, we confirmed that gga-miR-19a was up-regulated in both
MG-infected chicken embryonic lungs andMG-infected DF-1 (chicken embryo fibroblast)
cells. At 72 h post-transfection, we found that the over-expression of gga-miR-19a
significantly enhanced the proliferation of MG-infected DF-1 cells by promoting the
transition from the G1 phase to the S and G2 phases, while a gga-miR-19a inhibitor
repressed the proliferation of MG-infected DF-1 cells by arresting the cell cycle in
the G1 phase. Moreover, we found that gga-miR-19a regulated the expression of
the host zinc-finger protein, MYND-type containing 11 (ZMYND11), through binding
to its 3′ untranslated region (3′-UTR). DAVID analysis revealed that ZMYND11 could
negatively regulate the NF-kappaB (NF-κB) signaling pathway in chickens (Gallus gallus).
Upon MG infection, gga-miR-19a, NF-κB, MyD88, and TNF-α were all up-regulated,
whereas ZMYND11 was down-regulated. The over-expression of gga-miR-19a in the
DF-1 cells did not affect the above gene expression patterns, and gga-miR-19a inhibitor
repressed the expression of NF-κB, MyD88, and TNF-α, but enhanced the expression
of ZMYND11. In conclusion, gga-miR-19a might suppress the expression of ZMYND11
in MG-infected chicken embryonic lungs and DF-1 cells, activate the NF-κB signaling
pathway, and promote pro-inflammatory cytokines expression, the cell cycle progression
and cell proliferation to defend against MG infection.
Keywords: Mycoplasma gallisepticum (HS strain), chicken, gga-miR-19a, cell cycle, ZMYND11, NF-κB signaling
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INTRODUCTION
Mycoplasma, an important prokaryote, can infect humans,
wildlife, and a wide range of economically important livestock
species (Gambarini et al., 2009; Osman et al., 2009; Nicholas and
Ayling, 2016). One of the most important Mycoplasma species,
Mycoplasma gallisepticum (MG) is the causative pathogen of
avian chronic respiratory disease (CRD) (Ley, 2003), which is
invasive and causes severe inflammation in the tracheas and lungs
of chickens and turkeys around the world (Davidson et al., 1982;
Yoder, 1991; Stipkovits et al., 2012). MG has been shown to
invade, survive and multiply inside chicken fibroblasts and HeLa
cells (Winner et al., 2000). After infection, MG is very difficult
to be eliminated from chicken farms. Although, vaccination and
antibiotics can be used to control the infection, it is impossible to
completely clear MG from infected chickens. As a consequence,
mycoplasmosis is causing huge economic losses to the poultry
industry worldwide (Pennycott et al., 2005).
Micro-ribonucleic acids (miRNAs), at 22–25 nucleotides long,
are small non-coding single-strand RNAs that negatively regulate
gene expression by interfering with post-transcriptional protein
translation (Zamore and Haley, 2005; Valencia-Sanchez et al.,
2006; O’Reilly, 2016). It has been suggested that up to 30% of
human genes are regulated by miRNAs (Di Leva et al., 2006). So
far, over 24, 000 (in total) and 859 (in chickens) miRNAs have
been identified (http://www.mirbase.org/), but only a few have
been functionally studied.
miRNAs play important roles in regulatory pathways,
including various physiological and pathological processes (Lim
et al., 2003; Ambros, 2004). Emerging data are showing
that miRNAs contribute to the development and control of
inflammatory responses in both immune and non-immune cells
(Bazzoni et al., 2009; Perry et al., 2009).
Current studies suggest that miRNAs are involved in various
diseases of poultry, such as avian influenza (Wang et al., 2009),
avian leucosis (Wang Q. et al., 2013; Li H. et al., 2014), ovarian
carcinoma (Lee et al., 2012), infection bursal disease (Wang Y.
S. et al., 2013), and Marek’s disease (Yao et al., 2008; Lian et al.,
2012; Stik et al., 2013; Li X. et al., 2014). Our previous study has
shown that gga-miR-101-3p plays a crucial role in MG infection
by regulating EZH2 expression (Chen et al., 2015). The functional
study of miRNAs could help to reveal molecular pathways
involved in microbial pathogenesis and provide a theoretical
basis for miRNA-mediated gene therapy. However, no expression
profiles of miRNAs have been reported in MG-infected chickens.
As a major transcriptional factor, nuclear factor-kappaB (NF-
κB) regulates genes involved in innate and adaptive immunity,
cell proliferation, differentiation and inflammation, especially
the rapid response to pathogen infection and pro-inflammatory
stimuli (Lindsay, 2008; Yoshida et al., 2013). Activation of
the NF-κB signaling cascade results in the expression of pro-
inflammatory cytokines and chemokines (Hayden and Ghosh,
2008). miRNAs are also involved in modulating the NF-κB
signaling pathway (Lecellier et al., 2005; Ma et al., 2011a;
Wendlandt et al., 2012).
miR-19a is up-regulated in a variety of human cancers,
including lung cancer (Navarro et al., 2009), colon cancer
(Zhang J. et al., 2012), cervical carcinoma (Xu et al., 2012),
breast cancer (Zhang et al., 2011), gliomas (Jia et al., 2013),
gastric cancer (Wu et al., 2014), and bladder cancer (Feng et al.,
2014). miR-19a might regulate the NF-κB signaling pathway
in inflammation (Gantier et al., 2012; Ye et al., 2012). Our
preliminary deep sequencing data revealed that gga-miR-19a
is up-regulated in MG-infected embryonic lungs (unpublished
lab data), which suggests that gga-miR-19a might play a
crucial role in the response to MG infection. In this study,
we further demonstrate that gga-miR-19a is significantly up-
regulated in MG-infected chicken embryonic lungs and DF-1
cells. Furthermore, we identified ZMYND11 as a gga-miR-19a
target and followed up with a detailed miRNA regulation of
ZMYND11 expression, the cell cycle, cell proliferation and the
NF-κB signaling pathway in the context of MG infection.
MATERIALS AND METHODS
Ethics Statement
Our experimental protocols for chicken-embryo treatment were
approved by the Institutional Animal Care andUse Committee of
Huazhong Agricultural University. The procedures were carried
out in accordance with the approved guidelines.
gga-miR-19a Target Analysis
Potential gga-miR-19a targets were predicted by TargetScan
(http://www.targetscan.org/) and miRDB (http://www.mirdb.
org/miRDB/). The duplex and minimum free energy (mFE)
between gga-miR-19a and 3′-UTR of its potential targets were
estimated by RNA hybrid (http://bibiserv.techfak.uni-bielefeld.
de/rnahybrid/). The conservation of the target gene was analyzed
by TargetScan (http://www.targetscan.org/). The functions of the
target genes of gga-miR-19a in chickens were analyzed using
DAVID Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.
gov/).
Design of DNA Primers and Synthesis of
RNA Oligonucleotides
The sequences of all the primers used in this study are
listed in Table 1. The sequences of RNA oligonucleotides are
shown in Table 2. A gga-miR-19a mimics (denoted as miR-
19a) and an inhibitor (denoted as miR-19a-Inh) were designed
and synthesized by GenePharma (Shanghai, China). A random
miRNA mimics that had not been found to suppress any chicken
target genes (denoted as miR-19a-NC), and a random miRNA
inhibitor that had not been found to promote any chicken target
genes (denoted as miR-19a-Inh-NC) were also designed and
synthesized to serve as the negative controls.
Mycoplasma Strains and Cell Culture
MG-HS is a virulent strain isolated from a chicken farm in
Hubei province, China (Bi and Ji, 1988; Bi and Xu, 1997). The
strain was deposited and donated by the State Key Laboratory
of Agricultural Microbiology, College of Veterinary Medicine,
Huazhong Agricultural University (Wuhan, Hubei 430070,
China). MG-HS culture and concentration determination were
carried out as previously described (Bi and Ji, 1988), and its viable
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TABLE 1 | Sequences of DNA primers.
Name Primer sequence (5′-3′) Accession no.
PRIMERS FOR 3′-UTR CLONING
ZMYND11 3′-UTR-F TTCCTCGAGTAGAACATCAC XM-004939164
ZMYND11 3′-UTR-R AATGCGGCCGCCATCAAGGTAG
TATGCTTCGTTT
XM-004939164
PRIMERS FOR RT-qPCR
GAPDH-F GAGGGTAGTGAAGGCTGCTG NM-204305
GAPDH-R CACAACACGGTTGCTGTATC NM-204305
RT- gga-miR-19a-3p CTCAACTGGTGTCGTGGAGTCGGC
AATTCAGTTGAGTCAGTTTT
MIMAT-0001112
gga-miR-19a-3p-F CTGGTAGGTGTGCAAATCCATG MIMAT-0001112
gga-miR-19a-3p-R GGTGTCGTGGAGTCGGCAAT MIMAT-0001112
gga-5s-rRNA-F CCATACCACCCTGGAAACGC
gga-5s-rRNA-R TACTAACCGAGCCCGACCCT
ZMYND11-F ACCAGCGATTCCTTCGTGAG XM-004939164
ZMYND11-R TGGGCTGAGGCATTGTGGGA XM-004939164
MyD88-F TCAGTTTGTCCAGGAGATG NM-001030962
MyD88-R GGTGTAATGAACCGCAAGATA NM-001030962
NF-κB-F GCCAGGTTGCCATCGTGT NM-205129
NF-κB-R CGTGCGTTTGCGCTTCTC NM-205129
TNF-α-F GGACAGCCTATGCCAACAAG XM-015294124
TNF-α-R ACACGACAGCCAAGTCAACG XM-015294124
TABLE 2 | Sequences of RNA oligonucleotides.
Name Sequences (5′-3′)
gga-miR-19a mimics UGUGCAAAUCUAUGCAAAACUGA
AGUUUUGCAUAGAUUUGCACAUU
gga-miR-19a NC sense UUCUCCGAACGUGUCACGUTT
gga-miR-19a NC antisense ACGUGACACGUUCGGAGAATT
gga-miR-19a inhibitor UCAGUUUUGCAUAGAUUUGCACA
gga-miR-19a inhibitor NC CAGUACUUUUGUGUAGUACAA
number in suspension was detected by a color-changing unit
(CCU) assay (Calus et al., 2010).
The immortalized chicken embryonic fibroblast cell line DF-
1 was obtained from the American Type Culture Collection
(Rockville, MD, USA) and cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA, USA)
supplemented with 10% fetal bovine serum (FBS, Invitrogen
Gibco Co., Carlsbad, CA, USA), 100 units of penicillin G and
100 µg of streptomycin (Beyotime Institute of Biotechnology,
Haimen, China) per milliliter, at 39◦C in a humidified 5% CO2
incubator.
gga-miR-19 Target Dual-Luciferase
Reporter Assay
To construct the dual luciferase reporter plasmid, the 3′-
UTR region of ZMYND11 covering the predicted gga-miR-19a
binding site was amplified by RT-PCR using the cDNA extracted
from the chicken embryo lung tissues as the template. The
amplified fragment was sub-cloned into the Xho I/Not I sites of
the psi-CHECKTM-2 vector (Promega, Madison, WI, USA). See
Table 1 for primer sequences. All PCR products were confirmed
by sequencing.
DF-1 cells were plated in 24-well plates at 2 × 105 cells
per well for the luciferase assay. Next, 200 ng of the luciferase
reporter plasmid and 10 pmol of miR-19a, miR-19a-NC, miR-
19a-Inh or miR-19a-Inh-NC were also transfected into DF-
1 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA). The cells were collected at 48 h post-transfection, and
the dual-luciferase activity was measured using a Lumat LB 9507
Ultra Sensitive Tube Luminometer (Titertek Berthold, Nanjing,
People’s Republic of China) according to the manufacturer’s
protocol (Promega, USA). The firefly luciferase activity of each
sample was normalized to the Renilla luciferase activity. Three
independent repeats were performed for all above transfection
experiments.
Infection Experiments
DF-1 cells were detached from cell culture vials by trypsin
treatment, evenly plated in six-well plates and then incubated in
the medium without antibiotics. The MG-infection experiments
were divided into an experimental group and a control group,
and each infection experiment was repeated three independent
times with three replicates of each sample. When the cells
in the experimental group reached 80–90% confluence, they
were infected with 100 µl of MG at the mid-exponential phase
(1 × 1010 CCU/ml). The cells in both groups were collected in
Trizol (Invitrogen, Carlsbad, CA, USA) for further use at 24
h post-infection. Infected-chicken embryonic lung tissues and
the controls were deposited in Key Laboratory of Agricultural
Animal Genetics, Breeding and Reproduction, Ministry of
Education, Huazhong Agricultural University (Wuhan, Hubei
430070, China).
Quantitative PCR
Total RNA was extracted from the cultured cells or the frozen
chicken embryonic lung tissues with TRIzol Reagent (Invitrogen,
Carlsbad, CA, USA). The purification of RNA was performed
using RNeasy mini columns according to the manufacturer’s
protocol (Qiagen; Valencia, CA). Using the Prime ScriptTM RT
reagent kit with gDNA eraser (TaKaRa, Tokyo, Japan), RT-qPCR
was performed using 1 µg of total RNA from each sample with
TransStart Top Green qPCR SuperMix (TRANSGEN, Beijing,
China) on the CFX96 or CFX384 TouchTM (Bio-Rad, Hercules,
CA, USA). The Ct (2−11Ct) method was used to calculate
relative expression of gga-miR-19, ZMYND11, NF-κB, MyD88,
andTNF-α (Livak and Schmittgen, 2001). The data were analyzed
using 7500 software v.2.0.1 (Applied Biosystems, Foster City,
CA, USA), with the automatic Ct used to determine the baseline
and threshold for Ct determination. 5S-RNA was used as an
internal control for miR-19a, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as an internal control for
ZMYND11, NF-κB, TNF-α andMyD88. The primers are listed in
Table 1. The experiment was performed three independent times
with three replicates of each sample, for a total of nine samples.
DF-1 cells were seeded in six-well plates at 6 × 103 cell/well
in 100 µl of DMEM containing 10% (v/v) FBS and incubated
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overnight at 39◦C with 5% CO2. Before transfection, the DF-1
cells were washed twice using phosphate-buffered saline (PBS),
and Opti-MEMI ReduMced Serum was added. Firstly, 200 µl of
Opti-MEMI ReduMced Serum and 6 µl of Lipofectamin 2000
(Invitrogen Life Technologies, USA) were added to centrifuge
tube A. Next, 7.5 pmol of miR-19a, miR-19a-NC, miR-19a-
Inh or miR-19a-Inh-NC, and 200 µl of Opti-MEMI ReduMced
Serum were added to tube B and reacted for 5 min at room
temperature. Next, tubes A and B were mixed for 20 min at
room temperature. The mixture of tubes A and B was added into
six-well plates and continuously incubated for 4 h with DMEM
containing 10% (v/v) FBS, 100 IU/ml penicillin G and 100 µg/ml
streptomycin to replace the previous medium. In addition, a
mock transfection was used as a blank control (denoted as
blank). The cells were collected at 48 h post-transfection. Total
RNA was extracted and purified, and RT-PCR was performed
in a TransStart Top Green qPCR SuperMix (TRANSGEN,
China) on CFX96 or CFX384 TouchTM (Bio-Rad, USA). The
transfections were performed three independent times. The
relative mRNA levels of NF-κB, MyD88 and TNF-α were
calculated using the 2−11Ct method (Livak and Schmittgen,
2001).
Western Blot Analysis
DF-1 cells were seeded in 24-well plates and transfected with
the indicated RNA oligonucleotides. Total proteins were isolated
from the DF-1 cells 48 h post-transfection using RIPA-buffer
(Beyotime, Beijing, China) with 100 mM phenylmethanesulfonyl
fluoride (PMSF). Protein concentrations were determined
with the bicinchoninic acid (BCA) protein assay reagent kit
(Beyotime, Beijing, China). Then, 10 µg of the total protein was
separated using 12% sodium dodecylsulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to polyvinylidene
fluoride (PVDF) membranes (Beyotime, Beijing, China) by
electrophoresis for 2 h at 80mA. Membranes were blocked
with 5% (w/v) fat-free milk at room temperature for 1 h. The
membrane was incubated overnight with primary antibodies
at 4◦C, including goat polyclonal anti-ZMYND11 (Santa Cruz,
Biotechnology, Inc. Santa Cruz, CA, USA) and rabbit anti-β-
actin, which served as a protein loading control. Then, the
membrane was washed and incubated with rabbit anti-goat
secondary antibody for 1 h. After three washes with TBST,
antigen-antibody complexes on the membranes were detected
using an enhanced chemiluminescence (ECL) detection system
(Bio-Rad, Hercules, CA, USA). All assays were performed in
triplicate.
Cell Proliferation and Cell Cycle Assays
A total of 6 × 103 DF-1 cells were plated in triplicate in six-well
plates in 100µl of DMEMmedium containing 10% (v/v) FBS and
incubated overnight at 39◦C in a humidified 5% CO2 incubator.
DF-1 cells were then transfected with miR-19a, miR-19a-NC,
miR-19a-Inh or miR-19a-Inh-NC, as described above. At 4 h
post-transfection, the cells then were infected with 7 µl of MG-
HS strain at 1010 CCU/ml. At 24 h, 48 h, 72 h post-transfection,
10 µl of the CCK-8 solution was added to each well of the
plate, which was then incubated at 39◦C for 4 h. The infected-
MG cells (denoted as miR-free MG+) and the uninfected-MG
cells (blank MG-) were used as controls. The blank MG-cells
were cultured in a sterile incubator to avoid MG contamination.
Cell proliferation was determined using the Cell Counting Kit-
8 according to the manufacturer’s protocol (CCK-8, DOJINDO,
Shanghai, China). The optical density at 450 nm of each well
plate wasmeasured using amicroplate reader (Bio-Rad, Hercules,
CA, USA).
The cell cycle assay was performed in 24-well plates. The DF-1
cells were transfected with gga-miR-19a, miR-19a-NC, miR-19a-
Inh or miR-19a-Inh-NC. At 4 h post-transfection, the cells were
infected with 7µl of MG-HS strain at 1010 CCU/ml. At 48 h post-
transfection, the cells were harvested, washed with ice-cold PBS,
and fixed in ice-cold 70% ethanol in PBS for 12 h. Similarly,
miR-free-MG+ and blank MG− were used as controls. The
cell cycle was analyzed with a flow cytometer, using the cell
cycle detection kit (KeyGEN, Nanjing, China). The percentages
of the cells in the G1, S and G2 phases were calculated. Three
replicate wells were included in each experimental group, and
all experiments were repeated independently in triplicate three
separate times.
Statistical Analysis
All assays were performed three times in triplicate, and all nine
values were applied to statistical analysis. The data are presented
as the mean ± SD and were analyzed by Student’s t-test. A
p <0.05 was considered statistically significant (∗P < 0.05,
∗∗P < 0.01).
RESULTS
Prediction of the Target Gene of
gga-miR-19a
Using miRNA deep sequencing, we previously found that
gga-miR-19a was up-regulated in infected chicken embryonic
lung tissues (unpublished lab data).
To identify the targets of gga-miR-19a, we carried out a
bioinformatics analysis using targetScan (http://www.targetscan.
org/) and miRDB (http://www.mirdb.org/miRDB/). ZMYND11
was listed as a potential gga-miR-19a target gene based on its
high score (score 98), and the highly conserved target site on
the 3′-UTR of ZMYND11 in a wide range of species, including
human, mouse, dog, monkey, platypus, etc. (Figure 1C). The
predicted target site is a 87–109 base sequence, and the potential
binding site is a 102–108 base sequence (Figure 1A). The
minimum free energy (mFE) between ZMYND11 3′-UTR
and gga-miR-19a was calculated in RNAhybrid software
(http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/). The mFE
was about −20.5 kCal/mol, which indicates high stability
(Figure 1B). The functions of ZMYND11 in chickens were
investigated using DAVID Bioinformatics Resources 6.7
(http://david.abcc.ncifcrf.gov/) (Ikeda et al., 2010), which
suggests negative regulation of the NF-κB signaling pathway
(Figure 1D).
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FIGURE 1 | Bioinformatics analysis of the target genes of gga-miR-19a. (A) Sequence schematic diagram of gga-miR-19a and the target site in the 3′-UTR of
ZMYND11. The seed sequence of gga-miR-19a is underlined, and the matching or complementary nucleotides between gga-miR-19a and ZMYND11 3′-UTR are
indicated; (B) The predicted secondary structure of the RNA duplex of gga-miR-19a and the ZMYND11 3′-UTR target site (Red: Target sequence; Green:
gga-miR19a); (C) Sequence alignment of ZMYND11 3′-UTR from different species. The conserved target sequences are highlighted; (D) Predicted function of the
target gene of gga-miR-19a.
ZMYND11 Is the Direct Target of
gga-miR-19a
To further clarify whether gga-miR-19a directly targets to the
3′-UTR of ZMYND11, we used a luciferase reporter gene assay
(psi-CHECKTM-2), where the firefly luciferase gene was fused
to the entire 3′-UTR of ZMYND11 (Luc-ZMYND11), and the
Renilla luciferase was used for normalization. A luciferase activity
assay was performed 48 h after co-transfection of DF-1 cells
with gga-miR-19a mimics (miR-19a) and the Luc-ZMYND11
(3′-UTR) vector. ZMYND11 3′-UTR luciferase activity was
significantly inhibited by gga-miR-19a, whereas no effect on
luciferase activity was observed in the miR-19a-NC-transfected
cells (Figure 2). However, when miR-19a-Inh was transfected
into the DF-1 cells, the luciferase activity was significantly
increased, even in the presence of gga-miR-19a. As expected,
miR-19a-Inh-NC did not have effects on ZMYND11 3′-UTR
luciferase activity (Figure 2). Altogether, these results indicate
that gga-miR-19a inhibited ZMYND11 gene expression by
directly binding to its complementary sequence in the 3′-UTR
of ZMYND11 in a sequence-specific manner.
gga-miR-19a Negatively Regulates
ZMYND11 Expression
Next, we examined the effect of gga-miR-19a on endogenous
ZMYND11 expression in detail. By using qPCR and a Western
blot, we studied the expression of ZMYND11 in DF-1 cells
that were transfected with miR-19a, miR-19a-NC, miR-19a-
Inh or miR-19a-Inh-NC. By transient transfection, gga-miR-
19a was over-expressed in DF-1 cells at 88.9 times the level of
endogenous gene expression (miR-19a-NC) (Figure 3A). gga-
miR-19amimics significantly decreased ZMYND11 expression at
both the mRNA level and protein levels at 48 h post-transfection
(Figures 3B,C). In contrast, the endogenous gga-miR-19a was
reduced 8.5-fold in the cells transfected with gga-miR-19a
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FIGURE 2 | Gga-miR-19a directly targets to ZMYND11. DF-1 cells were
co-transfected with Luc- ZMYND11 (3′-UTR) and the indicated RNA
oligonucleotides. Luciferase activity was assayed at 24 h post-transfection.
The firefly luciferase activity of each sample was normalized to the Renilla
luciferase activity. All values are represented as the mean ± SD of three
independent experiments in triplicate and were analyzed by Student’s t-test.
Significant differences are denoted as **P < 0.01.
inhibitor (Figure 4A), which led to the increased expression of
ZMYND11 at both the mRNA and protein levels at 48 h post-
transfection (Figures 4B,C). These results indicate that gga-miR-
19a down-regulates ZMYND11 expression through binding to
the ZMYND11 3′-UTR in DF-1 cells.
gga-miR-19a Promotes the Proliferation of
MG-Infected DF-1 Cells by Inducing the G1
Phase Transition into the S and G2 Phases
To elucidate the biological significance of gga-miR-19a in MG-
HS pathogenicity, we transfected DF-1 cells with gga-miR-19a
mimics and then infected the cells with 7 µl of MG-HS strain
at 1010 CCU/ml [denoted as miR-19a (MG+)]. In parallel, we
prepared three control groups. One was transfected with miR-
19a-NC and then infected with 7 µl of MG-HS strain at 1010
CCU/ml [denoted as miR-19a-NC (MG+)]; the second was
infected with only 7 µl of MG-HS strain at 1010 CCU/ml
[denoted as miR-free (MG+)]; and the third group consisted
of the uninfected DF-1cells [denoted as blank (MG−)]. The
proliferation of DF-1 cells was measured at 24, 48, and 72 h
post-transfection using the Cell Counting Kit-8. During the first
48 h post-transfection, a decrease in cell viability was observed
in all MG-infected groups (including miR-19a-NC, miR-free and
over-expressed miR-19a) compared to the blank MG- group.
At 72 h post-transfection, although the cell viability of the
two control groups, miR-19a-NC (MG+) and miR-free (MG+),
remained low, a remarkable increase in DF-1 cell proliferation
was observed in the cells over-expressed gga-miR-19a. As a result,
the cell viability of the blank MG- group and the test group
over-expressing gga-miR-19a (MG+) reached the same level at
72 h post-transfection (Figure 5A). Next, we studied the effects of
miR-19a inhibitor on cell proliferation. After miR-19a inhibitor
was transfected into DF-1 cells (miR-19a-Inh), the expression of
gga-miR-19a was significantly repressed. As expected, this change
resulted in a significant reduction in the proliferation of DF-1
cells at 72 h post-transfection, compared to proliferation in the
blank MG- group. We also observed a significant reduction in
proliferation compared to the miR-19a-Inh-NC (MG+) group
or the miR-free group (MG+) (Figure 5B). In summary, our
results suggest that gga-miR-19a enhances DF-1 cell proliferation
by inhibiting MG propagation.
To further investigate how gga-miR-19a regulates DF-1 cell
proliferation, the distribution of cells in different stages of the cell
cycle was assayed with a flow cytometer. Similarly, the synthetic
RNA oligonucleotides were transfected into DF-1 cells. MG
infection inhibited mitosis by inducing the G1 cell cycle arrest in
the DF-1 cells. The over-expression of gga-miR-19a significantly
increased the percentage of the S and G2 phases cells, whereas
the percentage of the G1 phase cells was significantly decreased
compared to that in the control groups except for the blank
(MG-) (Figure 6). On the contrary, gga-miR-19a-Inh arrested the
cell cycle progression at the G1 phase (Figure 7).
Taken together, these results indicate that gga-miR-19a
inhibits MG propagation, and promotes the proliferation of DF-1
cells by affecting the cell cycle.
Expression of gga-miR-19a, ZMYND11,
NF-κB, TNF-α,and MyD88in MG-Infected
DF-1 Cells and Chicken Embryonic Lungs
It was shown that ZMYND11 could negatively regulate the NF-κB
signaling pathway in chickens by DAVID analysis (Figure 1D).
We demonstrated that gga-miR-19a was significantly up-
regulated in MG-infected DF-1 cells relative to its expression in
non-infected DF-1 cells (Figure 8A), whereas the expression of
ZMYND11mRNAwas significantly down-regulated (Figure 8B).
As expected, the expression of NF-κB, TNF-α and MyD88 were
also significantly up-regulated (Figure 8C).
Subsequently, we examined the effects of MG infection on the
expression of the above genes in vivo by injecting the chicken
embryos with MG-HS on the 9th hatching day. On the 4, 5,
11, and 12th days post-infection (equivalent to the 12, 13, 19,
and 20th days of egg hatching), the expression of gga-miR-
19a was significantly higher in MG-infected chicken embryonic
lungs (Figure 9A). As expected, the expression of ZMYND11
showed a pattern opposite that of gga-miR-19a on the 4, 5,
11, and 12th days post-infection (Figure 9B). As in the in vivo
experiments, the expression patterns ofNF-κB (Figure 9C),TNF-
α (Figure 9D) and MyD88 (Figure 9E) in lungs were similar to
those of gga-miR-19a throughout the test stages after infection.
These results were consistent with the predictions obtained by
bioinformatics, and indicated that MG-infection could enhance
the expression of gga-miR-19a, NF-κB, TNF-α and MyD88, but
inhibited that of ZMYND11.
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FIGURE 3 | Gga-miR-19a inhibits ZMYND11 expression. (A) Over-expression of gga-miR-19a in DF-1 cells; (B) The level of ZMYND11 mRNA in DF-1 cells
over-expressing gga-miR-19a was determined by RT-qPCR; (C) Western blot was performed to analyze ZMYND11 protein expression in DF-1 cells at 48 h post-
transfection with gga-miR-19a. A mock transfection was used as the blank. GAPDH was used as an internal quantitative control. All values are represented as the
mean ± SD of three independent experiments in triplicate. Significant differences are denoted as **P < 0.01.
gga-miR-19a Regulates the NF-κB
Signaling Pathway in DF-1 Cells
To determine the effects of gga-miR-19a on NF-κB activity,
DF-1 cells were transfected with gga-miR-19a, miR-19a-NC,
miR-19a-Inh or miR-19a-Inh-NC for 48 h. The over-
expression of gga-miR-19a, but not miR-19a-NC, resulted in a
significant increase in NF-κB, TNF-α, and MyD88 expression
(Figures 10A–C). Conversely, NF-κB, TNF-α, and MyD88
expression were greatly inhibited by the over-expression of
miR-19a-Inh (Figures 11A–C). These results suggest that gga-
miR-19a positively regulates the activity of the NF-κB signaling
pathway in inflammation by inhibiting ZMYND11 expression.
DISCUSSION
It is well documented that miRNAs are critical regulators of
gene silencing that exert their function through suppressing
translation or/and promoting degradation of targeted mRNAs.
They have important regulatory functions in multiple cellular
processes, including immune responses, cellular differentiation,
cellular proliferation, cell apoptosis, and inflammation (Ambros,
2004; Bartel, 2004, 2009). Accumulating evidence indicates that
microbial infections can alter the expression of cellular miRNAs
in chickens (Wang et al., 2009; Wang Y. S. et al., 2013; Lee et al.,
2012; Lian et al., 2012; Li X. et al., 2014). Moreover, the miR-
17-92 cluster (miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1
and miR-92-1) has been reported to be frequently over-expressed
in human cancers and has oncogenic activity (He et al., 2005;
Mendell, 2008). Our previous deep sequencing results showed
that some host miRNAs were aberrantly expressed, and gga-
miR-19a was up-regulated in lungs of MG-infected SPF chicken
embryos (unpublished lab data). Consistent with these results,
this study found that gga-miR-19a expression was significantly
increased in MG-infected DF-1 cells (Figure 8A) and chicken
embryonic lungs on the 4, 5, 11, and 12th days post-infection
(Figure 9A). Moreover, we identified ZMYND11 as the target
gene of gga-miR-19a (Figure 2). The ZMYND11 gene showed
opposite expression patterns in DF-1 cells and the lung tissues
(Figures 8B, 9B.) These results also confirm that gga-miR-19a
was up-regulated in cells and tissues infected by MG and could
directly and negatively regulate ZMYND11 expression by binding
to the 3′UTR of ZMYND11mRNA.
Mycoplasma causes severe inflammation in humans and
animals and induces a series of pro-inflammatory cytokines in
a variety of cell types (Muzio et al., 2000; Barton and Medzhitov,
2003; Beutler, 2004).Mycoplasma fermentans lipoproteins trigger
inflammatory responses via activation of TLR2 and TLR6,
followed by activation of NF-κB (Takeuchi et al., 2000; Nishiguchi
et al., 2001). In our previous study, TLR2 and TLR6 were up-
regulated upon MG infection. This event was followed by up-
regulation of the downstream NF-κB-mediated inflammatory
responses (Tian et al., 2016).
The NF-κB signaling pathway is extensively involved in
inflammatory responses to microbial infections (Hayden
and Ghosh, 2011; Newton and Dixit, 2012). It promotes
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FIGURE 4 | Inhibition of gga-miR-19a increases ZMYND11 expression. (A) Transfection of miR-19a-Inh reduced the expression of gga-miR-19a in DF-1 cells;
(B) Transfection of miR-19a-Inh increased the expression of ZMYND11 in DF-1 cells; (C) Western blot was performed to analyze ZMYND11 protein expression in DF-1
cells at 48 h post-transfection with miR-19a-Inh. A mock transfection was used as the blank; the expression of GAPDH was used as a loading control. All values are
represented as the mean ± SD of three independent experiments in triplicate. Significant differences are denoted as **P < 0.01.
FIGURE 5 | The effect of gga-miR-19a on DF-1 cell proliferation. DF-1 cells were transfected with gga-miR-19a, miR-19a-NC, miR-19a-Inh or miR-19a-Inh-NC
and were incubated for 4 h. The cells were then infected with the MG-HS strain. Four control groups, including miR-19a-NC (MG+), miR-19a-Inh-NC (MG+), miR-free
(MG+) and the blank (MG−), were used. At 24, 48, and 72 h post-transfection, cell proliferation was detected using CCK-Cell Counting Kit-8a. All values are
represented as the mean ± SD of three independent experiments in triplicate. The asterisks represented statistically significant differences (*P < 0.05, **P < 0.01). (A)
The over-expression of gga-miR-19a dramatically promotes DF-1 cell proliferation; (B) Inhibitor of gga-miR-19a inhibites the proliferation of DF-1 cells.
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FIGURE 6 | The effect of the over-expression of gga-miR-19a on the distribution of DF-1 cells in the cell cycle. DF-1 cells were transfected with
gga-miR-19a or miR-19a-NC and were incubated for 4 h. The cells then were infected with MG-HS strain. Three control groups, including miR-19a-NC (MG+),
miR-free (MG+) and blank (MG−), were used. At 48 h post-transfection, the cell phase distribution was analyzed using a flow cytometer. Three independent
experiments were performed in triplicate. All values are represented as the mean ± SD. Significant differences are denoted as **P < 0.01.
pro-inflammatory cytokines expression (e.g., TNF-α, IL-6 and
IL-8) and plays an important role in the regulation of innate
and adaptive immunity (Gao et al., 2014; Giles et al., 2016;
Yang and Wang, 2016). These host defense mechanisms are
highly conserved, including induction of cell proliferation to
protect the host from infection (Lemaitre and Hoffmann, 2007;
Panayidou et al., 2014). A number of miRNAs are known to
participate in the regulation of the NF-κB signaling pathway at
multiple steps, thus affecting the outcome of microbial infection
(Lecellier et al., 2005; Ma et al., 2011b). miR-146 is an immune
system regulator and plays a key role in regulating different
types of diseases (Jopling et al., 2005). For example, miR-146a
down-regulates the expression of TRAF6 and IRAK1 to suppress
the activity of the NF-κB signaling pathway and has a key
role in suppressing tumorigenesis and tumor progression by
inhibiting tumor cell migration and invasion (Taganov et al.,
2006). In HCV- or HIV-infected cells, the up-regulation of
miR-155 and miR-21 represses the NF-κB signaling pathway
(Houzet et al., 2008; Marquez et al., 2010; Zhang Y. et al., 2012).
During HIV infection, the down-regulation of miR-16 results in
the activation of the NF-κB signaling pathway, thus enhancing
immune responses (Li et al., 2010). miR-301a promotes the
activation of the NF-κB signaling pathway by down-regulating
NF-κB inhibiting factors (Lu et al., 2011). miR-9 inhibits ovarian
and gastric cancer cell growth through modulation of the
NF-κB signaling pathway (Guo et al., 2009; Wan et al., 2010;
Wang et al., 2010). miR-19 regulates the activity of the NF-κB
signaling pathway to produce pro-inflammatory cytokines in
inflammation (Gantier et al., 2012). Earlier studies have shown
that ZMYND11 negatively regulated Epstein-Barr virus latent
membrane protein 1-mediated NF-κB activation and then
enhanced IL-6 expression (Ikeda et al., 2009, 2010). In this study,
analysis using DAVID bioinformatics resources 6.7 indicated
that ZMYND11 could negatively regulate the NF-κB signaling
pathway in chickens. In the in vivo experiments, MG infection
resulted in a significant increase of gga-miR-19a, NF-κB, TNF-α
and MyD88 expression but a dramatic decrease in ZMYND11
expression (Figures 9A–E). In the in vitro experiments, the
over-expression of gga-miR-19a resulted in a significant increase
in NF-κB, TNF-α and MyD88 expression at mRNA levels in
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 September 2016 | Volume 6 | Article 102
Hu et al. gga-miR-99a Helps Anti-MG-HS in Chickens
FIGURE 7 | The effect of gga-miR-19a inhibitor on the distribution of DF-1 cells in the cell cycle. DF-1 cells were transfected with miR-19a-Inh or
miR-19a-Inh-NC and were incubated for 4 h. The cells were then infected with MG-HS strain. Three control groups, including miR-19a-Inh-NC (MG+), miR-free
(MG+) and blank (MG−), were used. At 48 h post-transfection, the cell cycle was analyzed using a flow cytometer. All values are represented as the mean ± SD of
three independent experiments in triplicate. Significant differences are denoted as **P < 0.01.
DF-1 cells (Figures 10A–C), whereas gga-miR-19a inhibitor
drastically inhibitedNF-κB, TNF-α andMyD88 expression at the
mRNA level (Figures 11A–C). However, ZMYND11 showed the
opposite pattern of expression in DF-1 cells (Figures 3B, 4B).
Our results suggest that gga-miR-19a might play a critical
regulatory role in activating the NF-κB signaling pathway to
produce pro-inflammatory cytokines by suppressing ZMYND11
expression. gga-miR-19a might play an important role in the
pathogenesis of MG infection by regulating the MyD88/NF-κB
signaling pathway.
Activation of NF-κB results in the production of pro-
inflammatory cytokines and affects cell proliferation (Gao et al.,
2014; Yang and Wang, 2016). NF-κB promotes melanoma
cell proliferation via miR-7-5p (Giles et al., 2016). The up-
regulation of miR-181a activates the NF-κB signaling pathway
to promote colorectal cancer cell proliferation and increase
host anti-infection activity (Hai et al., 2016). The significant
up-regulation of miR-301a enhances NF-κB expression to
promote cell proliferation, migration and invasion in human
hepatocellular carcinoma (Xie et al., 2015). gga-miR-221/222
suppresses the cell cycle of T-cell lymphoma in Marek’s disease
(MD) (Lambeth et al., 2009), and gga-miR-181a and gga-miR-
26a inhibit proliferation of Marek’s disease lymphoma cells
(Li X. et al., 2014; Lian et al., 2015). The miR-17-92 cluster
that is over-expressed in ESCC improves esophageal cellular
proliferation both in vitro and in vivo and enhances the cell
cycle progression in tumor cells (Hayashita et al., 2005; Liu et al.,
2011). The up-regulation of miR-19a and miR-19b promotes
cervical carcinoma cell proliferation and invasion by targeting
CUL5 (Xu et al., 2012). We found that MG infection inhibits
mitosis by blocking the transition from the G1 phase to the S
and G2 phases in DF-1 cells (Figures 6, 7). The over-expression
of gga-miR-19a accelerated the cell cycle progression to promote
proliferation by enhancing the percentages of DF-1cells in the
S and G2 phases (Figure 6), whereas the gga-miR-19a inhibitor
repressed proliferation of the DF-1 cells by inducing the G1
phase arrest (Figure 7). Together, the results suggest that the up-
expression of gga-miR-19a inhibits MG infection by improving
cell proliferation through inducing the transition from the G1
phase to the S and G2 phases.
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FIGURE 8 | Effects of MG infection on the expression of gga-miR-19a, ZMYND11, NF-κB, TNF-α, and MyD88 in DF-1 cells. The DF-1 cells were infected
with MG-HS as described in the Material and Methods, and the total RNA was extracted. (A) gga-miR-19a expression was assessed by RT-qPCR, using 5S-rRNA as
an internal quantitative control; (B) ZMYND11 mRNA expression was assessed by RT-qPCR, using GAPDH as an internal quantitative control; (C) NF-κB, TNF-α and
MyD88 mRNA expression was assessed by RT-qPCR, using GAPDH as an internal quantitative control. All values are represented as the mean ± SD of three
independent experiments in triplicate. Significant differences are denoted as **P < 0.01.
FIGURE 9 | Effects of MG infection on the expression of gga-miR-19a, ZMYND11, NF-κB, TNF-α and MyD88 in the lungs of chicken embryos. The
chicken embryos were infected by MG-HS as described in the Material and Methods. On the 4, 5, 11, and 12th days post-infection, the lungs of infected chicken
embryos were processed, and the expression of gga-miR-19a (A), ZMYND11 (B), NF-κB (C), TNF-α (D), and MyD88 (E) were measured by RT-qPCR. All samples
were normalized to GAPDH. All values are represented as the mean ± SD of three independent experiments in triplicate. Significant differences are denoted
as **P < 0.01.
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FIGURE 10 | Over-expression of gga-miR-19a activates NF-κB, TNF-α and MyD88 in DF-1 cells transfected with gga-miR-19a or the negative control.
A mock transfection was used as a blank. At 48 h post-transfection, the expression of NF-κB (A), TNF-α (B), and MyD88 (C) were measured by RT-qPCR. A mock
transfection was used as the blank. All samples were normalized to GAPDH. All values are represented as the mean ± SD of three independent experiments in
triplicate. Significant differences are denoted as **P < 0.01.
FIGURE 11 | Inhibition of gga-miR-19a reduces NF-κB, TNF-α and MyD88 expression. DF-1 cells were transfected with miR-19a -Inh or the negative control.
At 48 h post-transfection, the expression of NF-κB (A), TNF-α (B) and MyD88 (C) were measured by RT-qPCR. A mock transfection was used as the blank, and the
expression of GAPDH was used as a loading control. All values are represented as the mean ± SD of three independent experiments in triplicate. Significant
differences are denoted as **P < 0.01.
In summary, our results strongly suggest that the up-
regulation of gga-miR-19a represses the expression of ZMYND11
in MG-infected cells and tissues, which in turn activates
the NF-κB signaling pathway and promotes cell proliferation
and the expression of pro-inflammatory cytokines to defend
against MG infection. Furthermore, gga-miR-19a and its
target gene ZMYND11are potential diagnostic biomarkers
and therapeutic targets in the prevention and treatment of
mycoplasmosis.
As both gga-miR-19a and ZMYND11 are highly conserved in
a wide range of species, including human, dog, cow, chimpanzee,
mouse, rat, monkey and platypus (Figure 1C), the results will
provide valuable insights into the relationship between miRNAs
and target genes in other species.
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